Capricor Therapeutics, Inc. (CAPR) earnings
Quarterly and annual CAPR reports and results, each read against the price at its own news timestamp. Back to the CAPR overview →
10 measured CAPR earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q CAPRICOR THERAPEUTICS, For: Jun 30 | SEC filing · Form 10-Q | -1.02% | +8.44% | |
| Capricor Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update | Press release | -7.09% | -13.52% | |
| Capricor Therapeutics to Report Second Quarter 2026 Financial Results and Provide Recent Corporate Update on August 13 | Press release | -0.37% | — | |
| Form 10-Q CAPRICOR THERAPEUTICS, For: Mar 31 | SEC filing · Form 10-Q | -2.39% | -2.26% | |
| Capricor Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update | Press release | +3.94% | -0.72% | |
| Capricor Therapeutics to Report First Quarter 2026 Financial Results and Provide Recent Corporate Update on May 12 | Press release | +0.89% | -2.25% | |
| Form 10-K CAPRICOR THERAPEUTICS, For: Dec 31 | SEC filing · Form 10-K | +0.13% | -1.12% | |
| Capricor Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update | Press release | +6.28% | +5.26% | |
| Form 10-Q CAPRICOR THERAPEUTICS, For: Sep 30 | SEC filing · Form 10-Q | +6.28% | +5.26% | |
| Capricor Therapeutics to Present Third Quarter 2025 Financial Results and Recent Corporate Update on November 10 | Press release | -0.63% | +2.52% |
Keep exploring
More CAPR: analyst actions → · SEC filings → · CAPR overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Mallinckrodt plc (MNK) | 1,580 | +0.04% | 53% |
| AmerisourceBergen Corporation (ABC) | 1,573 | +0.02% | 51% |
| CTI BioPharma Corp. (CTIC) | 1,481 | -0.33% | 39% |
| Elanco Animal Health Incorporated (ELAN) | 1,465 | +0.07% | 51% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.